Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NV-06: Began Phase I trial

Novogen Ltd. (NVGN; ASX:NRT), Sydney, Australia
Product:

Read the full 78 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE